Clinical Report: Mastering Myopia: Premyopia and Cycloplegic Considerations
Overview
This report discusses the significance of premyopia in children, emphasizing the role of cycloplegic refraction in identifying at-risk patients. It highlights effective interventions such as outdoor time and low-concentration atropine to manage myopia progression.
Background
Myopia is a growing global concern, particularly among children, necessitating early identification and intervention strategies. The concept of premyopia, defined by low hyperopia, serves as a critical marker for potential future myopia. Understanding the implications of cycloplegic refraction is essential for accurate diagnosis and management.
Data Highlights
Study
Findings
LAMP2 Trial
0.05% atropine reduced myopia incidence from 53.0% to 28.4% compared to placebo.
Guo et al. (2022)
Significant hyperopia detected post-cycloplegia in children initially classified as low hyperopes.
Wu et al. (2025)
Atropine showed less myopia than cyclopentolate in refraction outcomes.
Key Findings
Premyopia is defined as a refractive error of +0.75 D or less.
Cycloplegic refraction is crucial for accurate diagnosis of premyopia.
Outdoor time of 2 hours daily is beneficial in delaying myopia onset.
0.05% atropine effectively slows myopia progression in children.
Noncycloplegic refraction may underestimate hyperopia in children.
Clinical Implications
Practitioners should prioritize cycloplegic refraction to accurately identify premyopia and educate families on the importance of outdoor activities. Implementing low-concentration atropine as a preventive measure can significantly reduce the incidence of myopia in at-risk children.
Conclusion
Accurate identification and management of premyopia are essential in preventing future myopia. Continued research and adherence to established guidelines will enhance outcomes for pediatric patients.
Narrative review linked lower vitamin D levels to greater myopia risk and higher omega-3 intake to lower risk, though outdoor exposure may explain the vitamin D association.
